Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
UBS
Moodys
AstraZeneca
Queensland Health
Argus Health

Generated: May 25, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,834,059

« Back to Dashboard

Which drugs does patent 7,834,059 protect, and when does it expire?

Patent 7,834,059 protects NEVANAC and is included in one NDA.

This patent has twenty-six patent family members in twenty-two countries.

Summary for Patent: 7,834,059
Title:Topical nepafenac formulations
Abstract:Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration.
Inventor(s): Wong; Warren (Fort Worth, TX)
Assignee: Alcon, Inc. (Hunenberg, CH)
Application Number:11/292,484
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,834,059
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 7,834,059

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novartis Pharms Corp NEVANAC nepafenac SUSPENSION/DROPS;OPHTHALMIC 021862-001 Aug 19, 2005 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF TREATING OCULAR INFLAMMATION ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 7,834,059

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 052252 ➤ Try a Free Trial
Austria 476200 ➤ Try a Free Trial
Australia 2005311738 ➤ Try a Free Trial
Brazil PI0518904 ➤ Try a Free Trial
Canada 2586807 ➤ Try a Free Trial
China 101068573 ➤ Try a Free Trial
Cyprus 1110780 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Fuji
Colorcon
Queensland Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.